WED, 07 OCT 2026|
[BRAND]
LATEST
Economy · Finance

Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial

CNBC · World
Published 1 Oct 2026, 12:32 am·7 d ago·1 min read
Listen to this story
Read aloud by your device

Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.

Read the full story at CNBC · World
cnbc.com
Open ↗

Related